| Year | Paper |
|---|---|
| 2010 | Ait-Oufella H, Herbin O, Bouaziz JD, Binder CJ, Uyttenhove C, Laurans L, Taleb S, Van Vre E, Esposito B, Vilar J, Sirvent J, Van Snick J, Tedgui A, Tedder TF, Mallat Z. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med. 2010 Aug 2;207(8):1579-87. Epub 2010 Jul 5. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20603314 |
| 2010 | Baumann CL, Aspalter IM, Sharif O, Pichlmair A, Bluml S, Grebien F, Bruckner M, Pasierbek P, Aumayr K, Planyavsky M, Bennett KL, Colinge J, Knapp S, Superti-Furga G. CD14 is a co-receptor of Toll-like receptors 7 and 9. J Exp Med. 2010 Nov 22;207(12):2689-701. Epub 2010 Nov 15. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21078886 |
| 2010 | Bieghs V, Wouters K, Van Gorp PJ, Gijbels MJ, De Winther MP, Binder CJ, Lutjohann D, Febbraio M, Moore KJ, Van Bilsen M, Hofker MH, Shiri-Sverdlov R. Role of Scavenger Receptor A and CD36 in Diet-induced Non-alcoholic Steatohepatitis in Hyperlipidemic Mice. Gastroenterology. 2010 Jun;138(7):2477-86, 2486.e1-3. Epub 2010 Mar 2. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20206177 |
| 2010 | Binder CJ. Natural IgM Antibodies Against Oxidation-Specific Epitopes. J Clin Immunol. 2010 May;30 Suppl 1:S56-60. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20387104 |
| 2010 | Bluml S, Binder NB, Niederreiter B, Polzer K, Hayer S, Tauber S, Schett G, Scheinecker C, Kollias G, Selzer E, Bilban M, Smolen JS, Superti-Furga G, Redlich K. Anti-inflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritis. Arthritis Rheum. 2010 Jun;62(6):1608-19. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20155834 |
| 2010 | Boucheron N, Sharif O, Schebesta A, Croxford A, Raberger J, Schmidt U, Vigl B, Bauer J, Bankoti R, Lassmann H, Epstein MM, Knapp S, Waisman A, Ellmeier W. The protein tyrosine kinase Tec regulates a CD44hiCD62L-Th17 subset. J Immunol. 2010 Nov 1;185(9):5111-9. Epub 2010 Sep 24. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20870948 |
| 2010 | Bunk S, Sigel S, Metzdorf D, Sharif O, Triantafilou K, Triantafilou M, Hartung T, Knapp S, von Aulock S. Internalization and coreceptor expression are critical for TLR2-mediated recognition of lipoteichoic acid in human peripheral blood. J Immunol. 2010 Sep 15;185(6):3708-17. Epub 2010 Aug 16. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20713893 |
| 2010 | Burkard TR, Rix U, Breitwieser FP, Superti-Furga G, Colinge J. A computational approach to analyze the mechanism of action of the kinase inhibitor bafetinib. PLoS Comput Biol. 2010 Nov 18;6(11):e1001001. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21124949 |
| 2010 | Cardilo-Reis L, Witztum JL, Binder CJ. When monocytes come (too) close to our hearts. J Am Coll Cardiol. 2010 Apr 13;55(15):1639-41. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20378084 |
| 2010 | Colinge J, Rix U, Superti-Furga G. Novel global network scores to analyze kinase inhibitor profiles. 2010 Sep 9, ORSC & APORC, 305-313. Lecture Notes; Abstract: |
| 2010 | Dixit E, Boulant S, Zhang Y, Lee AS, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, Nibert ML, Superti-Furga G, Kagan JC. Peroxisomes are signaling platforms for antiviral innate immunity. Cell. 2010 May 14;141(4): 668-81. Epub 2010 May 6. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20451243 |
| 2010 | Guenzl P, Hainzl E, Matt U, Dillinger B, Mahr B, Knapp S, Binder BR, Schabbauer G. Anti-inflammatory properties of the phosphoinositide- 3 kinase (PI3K) pathway are mediated by IL- 10/DUSP regulation. J Leukoc Biol. J Leukoc Biol. 2010 Dec;88(6):1259-69. Epub 2010 Sep 30. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20884649 |
| 2010 | Hudson QJ, Kulinski TM, Huetter SP, Barlow DP. Genomic Imprinting Mechanisms In Embryonic And Extra-Embryonic Mouse Tissues. Heredity. 2010 Jul;105(1):45-56. Epub 2010 Mar 17. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20234385 |
| 2010 | Jager R, Gisslinger H, Passamonti F, Rumi E, Berg T, Gisslinger B, Pietra D, Harutyunyan A, Klampfl T, Olcaydu D, Cazzola M, Kralovics R. Deletions of the transcription factor Ikaros in myeloproliferative neoplasms. Leukemia. 2010 Jul;24(7):1290-8. Epub 2010 May 27. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20508609 |
| 2010 | Jager R, Kralovics R. Molecular basis and clonal evolution of myeloproliferative neoplasms. Haematologica. 2010 Apr;95(4):526-9. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20378573 |
| 2010 | Jager R, Kralovics R. Molecular pathogenesis of Philadelphia chromosome-negative chronic myeloproliferative neoplasms. Curr Cancer Drug Targets. 2010 Nov 10. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21062246 |
| 2010 | Jellusova J, Duber S, Guckel E, Binder CJ, Weiss S, Voll R, Nitschke L. Siglec-G Regulates B1 Cell Survival and Selection. J Immunol. 2010 Sep 15;185(6):3277-84. Epub 2010 Aug 20. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20729333 |
| 2010 | Knapp S, Frass M. Editorial: Sepsis. Wien Med Wochenschr. 2010 Mar;160(5-6):105-6. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20364411 |
| 2010 | Knapp S. Update on the role of Toll-like receptors during bacterial infections and sepsis. Wien Med Wochenschr. 2010 Mar;160(5-6):107-11. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20364412 |
| 2010 | Koerner MV, Barlow DP. Genomic imprinting – an epigenetic gene regulatory model. Curr Opin Genet Dev. 2010 Apr;20(2):164-70.Epub 2010 Feb 12. Review. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20153958 |
| 2010 | Li J, Rix U, Fang B, Bai Y, Edwards A, Colinge J, Bennett KL, Gao J, Song L, Eschrich S, Superti-Furga G, Koomen J, Haura EB. A chemical and phosphoproteomic characterization of dasatinib action in lung cancer. Nat Chem Biol. 2010 Apr;6(4):291-9. Epub 2010 Feb 28. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20190765 |
| 2010 | Muellner MK and Nijman SM. Giving Rho(d) Directions. Nat Chem Biol. 2010 Jun;6(6):397-8. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20479746 |
| 2010 | Nijman SM. Syntehtic lethality: General principles, utility and detection using genetic screens in human cells. FEBS Lett. 2010 Nov 19. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21094158 |
| 2010 | O’Sullivan RJ, Kubicek S, Schreiber SL, Karlseder J. Reduced histone biosynthesis and chromatin changes arising from a damage signal at telomeres. Nat Struct Mol Biol. 2010 Oct;17(10):1218-25. Epub 2010 Oct 3. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20890289 |
| 2010 | Pedersen TX, Binder CJ, Fredrikson GN, Nilsson J, Bro S, Nielsen LB. The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE-/- mice. Nephrol Dial Transplant. 2010 Aug;25(8):2486-91. Epub 2010 Feb 17. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20164045 |
| 2010 | Radwan M, Stiefvater R, Gruner T, Sharif O, Miller I, Marchetti-Deschmann M, Allmaier G, Gemeiner M, Knapp S, Kovarik P, Muller M, Strobl B. Tyrosine kinase 2 controls interleukin-1 production at the translational level. J Immunol. 2010 Sep 15;185(6):3544-53. Epub 2010 Aug 16. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20713887 |
| 2010 | Schabbauer G, Matt U, Gunzl P, Warszawska J, Furtner T, Hainzl E, Elbau I, Mesteri I, Doninger B, Binder BR, Knapp S. Myeloid PTEN promotes inflammation but impairs bactericidal activities during murine pneumococcal pneumonia. J Immunol. 2010 Jul 1;185(1):468-76. Epub 2010 May 26. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20505137 |
| 2010 | Sherbenou DW, Hantschel O, Kaupe I, Willis S, Bumm T, Turaga LP, Lange T, Dao KH, Press RD, Druker BJ, Superti-Furga G, Deininger MW. BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib. Blood. 2010 Oct 28;116(17):3278-85. Epub 2010 Jun 2. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20519627 |
| 2010 | Ubaida Mohien C, Hartler J, Breitwieser F, Rix U, Remsing Rix L, Winter GE, Thallinger GG, Bennett KL, Superti-Furga G, Trajanoski Z, Colinge J. MASPECTRAS 2: An Integration and Analysis Platform for Proteomic Data. Proteomics. 2010 Jul;10(14):2719-22. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20455215 |
| 2010 | Wojcik J, Hantschel O, Grebien F, Kaupe I, Bennett KL, Barkinge J, Jones RB, Koide A, Superti-Furga G, Koide S. A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain. Nat Struct Mol Biol. 2010 Apr;17(4):519-27. Epub 2010 Mar 28. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20357770 |
| 2010 | Wool GD, Cabana VG, Lukens J, Shaw PX, Binder CJ, Witztum JL, Reardon CA, Getz GS. 4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. FASEB J. 2010 Sep 27. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20876212 |